DE3873366D1 - Transdermale, elektrolytische zufuehrung von proteinen. - Google Patents

Transdermale, elektrolytische zufuehrung von proteinen.

Info

Publication number
DE3873366D1
DE3873366D1 DE8888101856T DE3873366T DE3873366D1 DE 3873366 D1 DE3873366 D1 DE 3873366D1 DE 8888101856 T DE8888101856 T DE 8888101856T DE 3873366 T DE3873366 T DE 3873366T DE 3873366 D1 DE3873366 D1 DE 3873366D1
Authority
DE
Germany
Prior art keywords
electrolytic
patient
composition
protein
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888101856T
Other languages
English (en)
Other versions
DE3873366T2 (de
Inventor
Dan Sibalis
Sanford Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Drug Delivery Systems Inc
Original Assignee
Drug Delivery Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery Systems Inc filed Critical Drug Delivery Systems Inc
Application granted granted Critical
Publication of DE3873366D1 publication Critical patent/DE3873366D1/de
Publication of DE3873366T2 publication Critical patent/DE3873366T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/44—Applying ionised fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
DE8888101856T 1987-02-10 1988-02-09 Transdermale, elektrolytische zufuehrung von proteinen. Expired - Fee Related DE3873366T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1289887A 1987-02-10 1987-02-10

Publications (2)

Publication Number Publication Date
DE3873366D1 true DE3873366D1 (de) 1992-09-10
DE3873366T2 DE3873366T2 (de) 1992-12-10

Family

ID=21757276

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888101856T Expired - Fee Related DE3873366T2 (de) 1987-02-10 1988-02-09 Transdermale, elektrolytische zufuehrung von proteinen.

Country Status (9)

Country Link
EP (1) EP0278473B1 (de)
JP (1) JP2670794B2 (de)
KR (1) KR970000232B1 (de)
AT (1) ATE79036T1 (de)
AU (1) AU609769B2 (de)
CA (1) CA1319608C (de)
DE (1) DE3873366T2 (de)
ES (1) ES2033349T3 (de)
MX (1) MX168981B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970011449B1 (ko) * 1988-01-29 1997-07-11 더 리전트 오브 디 유니버시티 오브 캘리포니아 이온전기 영동형 비침입 검체 채취 또는 이송 장치 및 방법
US5362307A (en) 1989-01-24 1994-11-08 The Regents Of The University Of California Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance
IE64891B1 (en) 1990-03-15 1995-09-20 Becton Dickinson Co Composition for increased skin concentration of active agents by iontophoresis
ES2208633T3 (es) * 1990-03-30 2004-06-16 Alza Corporation Dispositvoo de administracion iontoforetica.
CA2087087C (en) * 1992-01-22 2000-07-18 Burton H. Sage, Jr. Molecules for iontophoretic delivery
EP0683668A4 (de) * 1993-01-27 1997-12-29 Affymax Tech Nv Präparate und verfahren für eine transdermale arzneistoffverabreichung.
US5533971A (en) * 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport
US5505715A (en) * 1994-02-25 1996-04-09 Bristol-Myers Squibb Company Iontophoretic transdermal delivery of deoxyspergualin compounds
ATE258452T1 (de) * 1994-06-17 2004-02-15 Hisamitsu Pharmaceutical Co Elektrode für iontophorese und vorrichtung dafür
AU5274196A (en) * 1995-04-07 1996-10-23 Novartis Ag Transdermal system with electrodes as initialization system
US5624415A (en) * 1995-04-24 1997-04-29 Alza Corporation Reduction of skin irritation and resistance during electrotransport
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
IT1285405B1 (it) 1995-06-06 1998-06-03 Alza Corp Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto.
US5747453A (en) * 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
US6333189B1 (en) 1996-06-06 2001-12-25 Alza Corporation Method of making an electrotransport device
US6119036A (en) * 1997-03-26 2000-09-12 The Board Of Regents Of The University Of Oklahoma Iontophoretic transdermal delivery device
IL159273A0 (en) * 2003-12-09 2004-06-01 Transpharma Medical Ltd Transdermal delivery system for sustained release of polypeptides
CA2587657A1 (en) * 2004-11-30 2006-06-08 Transcutaneous Technologies Inc. Iontophoresis device
CA2619665A1 (en) 2005-09-15 2007-03-22 Tti Ellebeau, Inc. Rod type iontophoresis device
FR2950802B1 (fr) 2009-10-02 2012-02-03 Sartorius Stedim Biotech Sa Elaboration et/ou conservation d'un produit biopharmaceutique.
NZ707160A (en) * 2012-12-19 2016-08-26 Wockhardt Ltd A stable aqueous composition comprising human insulin or an analogue or derivative thereof
CN113087787B (zh) * 2021-05-19 2023-03-21 广西医科大学第二附属医院(广西医科大学第二临床医学院) 一种蚯蚓血红蛋白分离及纯化方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140801B (da) * 1975-01-15 1979-11-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
EP0092015A1 (de) * 1982-04-16 1983-10-26 Roland Brodard Ionisierungsvorrichtung
JPS59118167A (ja) * 1982-12-24 1984-07-07 株式会社アドバンス イオントフオレ−ゼ用導子並びに同プラスタ−構造体
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
JPS61259679A (ja) * 1985-05-14 1986-11-17 日東電工株式会社 イオントフオレ−ゼ生体電極用基剤組成物

Also Published As

Publication number Publication date
AU609769B2 (en) 1991-05-09
CA1319608C (en) 1993-06-29
DE3873366T2 (de) 1992-12-10
AU1098688A (en) 1988-08-11
JPS63200774A (ja) 1988-08-19
MX168981B (es) 1993-06-16
EP0278473A1 (de) 1988-08-17
ES2033349T3 (es) 1993-03-16
KR970000232B1 (ko) 1997-01-08
KR880009633A (ko) 1988-10-04
EP0278473B1 (de) 1992-08-05
JP2670794B2 (ja) 1997-10-29
ATE79036T1 (de) 1992-08-15

Similar Documents

Publication Publication Date Title
DE3873366T2 (de) Transdermale, elektrolytische zufuehrung von proteinen.
KR880009632A (ko) 폴리펩티드의 전해식 경피투여
AU644917B2 (en) Device and method for renewing electrodes during iontophoresis
CA1319578C (en) Transdermal drug delivery device
ATE255450T1 (de) Matrix für iontophorese
DK1196430T3 (da) Rensning og stabilisering af peptider og proteiner i farmaceutiske midler
DE69220808T2 (de) Vorrichtung zur verabreichung von heilmitteln
IE830207L (en) Fibrinogen formulation
ATE166387T1 (de) Adhäsionsvarianten
DE69630445D1 (de) Gerät zum behandeln von Herzstillständen
DE69512083T2 (de) Vorrichtung zur erhöhung der wirkstoffsverabreichung durch elektrotransport
DE58906984D1 (de) Aktivierung von gentechnologisch hergestellten, in Prokaryonten exprimierten Antikörpern.
DE3688463D1 (de) Einrichtung zur transdermalen applikation von heilmitteln und dazugehoerige elektroden.
DE3854631T2 (de) Pulsierendes transkutanes Arzneimittel-Abgabesystem.
CA2067820A1 (en) Iontophoresis device and method using a rate-controlling membrane
DE69530217D1 (de) Eine mikrodialysevorrichtung
JPS6483254A (en) Metal surface treatment agent for adhesion
DE3789088T2 (de) Transcutane Verabreichung von Aminen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee